Masimo Corp. (NASDAQ:MASI) CEO Joe E. Kiani sold 4,464 shares of the stock in a transaction on Tuesday, September 27th. The stock was sold at an average price of $60.01, for a total value of $267,884.64. Following the completion of the sale, the chief executive officer now owns 123,705 shares in the company, valued at approximately $7,423,537.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Masimo Corp. (NASDAQ:MASI) opened at 59.49 on Monday. The stock has a market cap of $2.94 billion, a price-to-earnings ratio of 31.20 and a beta of 0.70. The firm has a 50-day moving average price of $58.93 and a 200 day moving average price of $50.75. Masimo Corp. has a 1-year low of $33.03 and a 1-year high of $60.52.
Masimo Corp. (NASDAQ:MASI) last released its quarterly earnings data on Wednesday, August 3rd. The company reported $0.57 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.16. The company had revenue of $172.64 million for the quarter, compared to analyst estimates of $166.02 million. Masimo Corp. had a return on equity of 29.07% and a net margin of 15.40%. The firm’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 earnings per share. On average, equities research analysts anticipate that Masimo Corp. will post $2.02 EPS for the current fiscal year.
Institutional investors have recently added to or reduced their stakes in the company. Victory Capital Management Inc. raised its position in shares of Masimo Corp. by 76.9% in the second quarter. Victory Capital Management Inc. now owns 2,148 shares of the company’s stock valued at $113,000 after buying an additional 934 shares during the period. Tower Research Capital LLC TRC acquired a new position in shares of Masimo Corp. during the second quarter valued at approximately $116,000. Quantbot Technologies LP acquired a new position in shares of Masimo Corp. during the second quarter valued at approximately $155,000. Reynders McVeigh Capital Management LLC acquired a new position in shares of Masimo Corp. during the second quarter valued at approximately $203,000. Finally, Janney Capital Management LLC acquired a new position in shares of Masimo Corp. during the second quarter valued at approximately $205,000. 79.88% of the stock is currently owned by institutional investors.
MASI has been the topic of a number of recent analyst reports. Wedbush reiterated an “outperform” rating and issued a $63.00 target price (up previously from $60.00) on shares of Masimo Corp. in a research note on Thursday, August 4th. Piper Jaffray Cos. restated an “overweight” rating and set a $55.00 price target (up previously from $52.00) on shares of Masimo Corp. in a research note on Friday, August 5th. Finally, BTIG Research restated a “hold” rating on shares of Masimo Corp. in a research note on Friday, August 5th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $52.60.
Masimo Corp. Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.